Position in INCY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$51,731,457
+$11,200,003 QoQ
Shares Held
549,633
+33.9% QoQ
Ownership
0.275%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MACKENZIE FINANCIAL CORP holds $416,722,148 across 43 Biotechnology names. INCY ranks #3 (12.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
1,779,636 | $93,003,777 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
86,317 | $66,691,966 | |
| 3 | INCY |
Incyte Corp
This page
|
549,633 | $51,731,457 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
96,709 | $43,184,436 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
441,444 | $24,937,171 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
345,683 | $23,551,382 | |
| 7 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
6,306,425 | $17,847,182 | |
| 8 | RPRX |
Royalty Pharma plc
|
170,882 | $8,197,209 |
All Filings in INCY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $51,731,457 | 549,633 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $40,531,454 | 410,362 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $38,430,718 | 453,139 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $24,667,794 | 362,229 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $20,591,420 | 340,073 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $16,717,357 | 242,035 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $17,190,825 | 260,073 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $23,138,896 | 381,704 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $22,435,868 | 393,819 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $23,470,211 | 373,789 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $18,960,749 | 328,211 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $18,454,697 | 296,461 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $17,548,601 | 242,820 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $19,391,496 | 241,428 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $12,318,004 | 184,844 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $12,000,525 | 157,964 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $9,408,410 | 118,464 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,783,256 | 51,543 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,800,102 | 40,711 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $2,956,664 | 35,144 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $2,341,388 | 28,810 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,617,489 | 30,093 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,020,585 | 22,516 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,856,575 | 27,475 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||